For caregivers of children under 12 with a urea cycle disorder

Your family's experience is evidence.

Tell us what managing a urea cycle disorder (UCD) takes day to day, and what you would want a future treatment to change.

New treatments, including gene therapies, are being studied. What you tell us may help shape the questions researchers ask and how they judge whether a treatment makes a difference in daily life.

This is a research study run at the University of South Carolina.

Take the survey
About 20–25 minutes, online. You can skip any question and stop at any time.
See other ways to take part
Please note

This is a research study about experiences. It does not offer treatment, medical advice, or access to a clinical trial, and taking part does not affect your child's care or any services you receive.

Three oral syringes filled with liquid medicine and a white medicine bottle on a kitchen counter, in black and white.
Illustration: a morning's medicines drawn up in oral syringes.

Why family experience is part of the evidence

Researchers, regulators, and treatment developers increasingly rely on patient-experience evidence of what a condition is actually like to live with. For urea cycle disorders, that picture is still thin, particularly for children managed day to day at home rather than enrolled in a trial.

A bowl of pasta and blueberries on a digital kitchen scale beside a handwritten food log, in black and white.
Illustration: protein counted by the gram at every meal.

Gene therapies are being studied in people for some urea cycle disorders and are still in laboratory development for others. Many children are outside current trial eligibility, for reasons such as age, sex, clinical history, or which urea cycle disorder they have.

This study gathers evidence from families raising children with a urea cycle disorder, including those outside current trials, on the things that shape daily life: symptoms and management, the risk of metabolic crises and emergencies, effects on development, school, and family, the tradeoffs of current treatments, and the outcomes families consider most meaningful.

Portrait of Greg Trevors, in black and white.

I'm Greg Trevors, a researcher at the University of South Carolina, and I lead this study. I started it because my own family lives with a urea cycle disorder. If you have a question before you decide, email me at hello@ucdlisteningproject.org.

Four ways to take part

Choose one, or more than one. If you only have time for one, take the survey.

Start here

The survey

About 20–25 minutes, online

Structured questions covering daily management, symptoms, risks, and priorities. This gives the most consistent, comparable record across families.

Take the survey

An interview

30–60 minutes, on Microsoft Teams

A guided conversation, in your own words, for context a survey can't capture. Interviews are held on Microsoft Teams (camera optional) and, with your permission, audio-recorded and transcribed for analysis.

Request an interview

A voice memo or written note

About 15–30 minutes, on your own time

Respond to a few open prompts by recording a voice memo or writing a note, whenever it suits you. Submissions are transcribed for analysis. You don't need to prepare.

Send a voice memo or note

A listening session

About 90 minutes, on Microsoft Teams

A facilitated virtual session with other families: brief prepared remarks, group discussion, and anonymous live polls. Sessions are recorded with participants' permission. You can use a first name or pseudonym and keep your camera off.

Sign up for a session

Who can take part

Parents, legal guardians, and primary caregivers, 18 or older, of a child under 12 with a urea cycle disorder. Families managing frequent crises and families with few or none are all welcome. Girls with OTC deficiency who have symptoms are included, even if they have been described as carriers.

Urea cycle disorders include OTC deficiency, CPS1 deficiency, NAGS deficiency, citrullinemia type I (ASS1 deficiency), argininosuccinic aciduria (ASL deficiency), arginase 1 deficiency, HHH syndrome, and citrin deficiency. Families of children with lysinuric protein intolerance (LPI), which is often grouped with the urea cycle disorders, are also welcome.

We also invite the following families to take part. Because their experiences differ, these groups may be described and analyzed separately:

  • Families of children who have had a liver transplant, reporting on the years before the transplant
  • Families who have lost a child to a urea cycle disorder, reporting on the time their child was under 12

Not sure whether the study applies to you? Email hello@ucdlisteningproject.org, or start the survey: a few early questions will point you the right way.

What taking part involves

It's voluntary

Taking part is entirely your choice. You can skip any question, and you can stop at any time, for any reason, without giving one.

Time

The survey takes about 20–25 minutes, plus an optional extra section of about 10 minutes. An interview runs 30–60 minutes. A listening session runs about 90 minutes. A voice memo or written note takes about 15–30 minutes. If you agree to a brief follow-up to check our summary of what you told us, that takes about 15–20 minutes.

Compensation

Survey $60, individual interview $80, listening session $120, voice memo or written narrative $25, paid by electronic gift card sent to the email address you give on a separate contact form after the activity. Payment is not withdrawn if you skip questions or stop early after meaningful participation. You may decline compensation, for example if a payment could affect public-benefit eligibility, without any effect on your participation.

Your information and who sees it

Survey responses are collected in Qualtrics. Recordings, transcripts, and other study records are kept in University of South Carolina–approved secure storage, with access limited to the study team, and your contact and payment details are stored separately from your responses. Findings are reported in aggregate. De-identified data may be shared with other qualified researchers, including at advocacy organizations, universities, or organizations developing treatments, or placed in a research data repository, with identifying details removed first.

Quotes and recordings

Interviews, voice memos, and listening sessions are transcribed for analysis. Short quotes may be used in reports or publications, but your name will not be attached without your permission, and identifying details are removed or generalized.

Confidentiality

We protect your information and will not use your name in any report without your permission. Because urea cycle disorders are rare, we cannot guarantee that a determined reader could never recognize a family from a combination of details, so we remove or generalize identifying information in anything we share. In a listening session, other participants will hear what you share; we ask everyone to keep the session confidential, but we cannot guarantee that they will.

Full details, including your rights as a participant, are in the study information sheet, which you will also see before the survey begins.

Count us in

Share your family's experience through the survey, an interview, a voice memo or written note, or a listening session.

Take the survey
Take the survey · 20–25 min